Tenax Therapeutics (TENX) Market Performance Summary
Trading Activity
- Price Movement: The share price of Tenax Therapeutics increased by 7.24 % during the 24‑hour period ending at 06:14 AM Central Europe time on Thursday, 22 October 2026.
- Current Price: One share is priced at approximately USD 1.63 on major exchanges.
- Volume and Capitalisation:
- Shares Outstanding: 57.3 million.
- Market Capitalisation: USD 87.1 million.
- Trading Volume (last 24 h): USD 2.4 million.
- Year‑to‑Date Performance: The stock has decreased by 13.3 % since the end of the previous month.
Technical Indicators
- Simple Moving Average (200 days): USD 10.56.
- 52‑Week High: USD 19.4 (recorded on 9 July 2026).
- 52‑Week Low: USD 1.31 (recorded on 10 August 2026).
Peer Performance (Last 24 h)
| Stock | Symbol | 24‑h Movement | Current Price | Market Capitalisation |
|---|---|---|---|---|
| Black Diamond Therapeutics I | BDTX | +14.36 % | USD 2.08 | USD 104 million |
| Apyx Medical | APYX | +0.83 % | USD 2.51 | USD 101.9 million |
| Elite Express | ETS | -0.96 % | USD 2.16 | USD 101.3 million |
| Pine Tree Acquisition | PAXGU | 0 % | USD 9.99 | USD 101.3 million |
| Inovio | INO | +1 % | USD 0.80 | USD 103.4 million |
Company Overview
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on biotechnology within the health‑care sector. The company is headquartered in Morrisville, United States. Its mission is to develop and commercialise products for the critical care market, particularly treatments for pulmonary hypertension associated with heart failure and preserved ejection fraction (PH‑HFpEF). Tenax Therapeutics utilizes levosimendan as an active ingredient in its product development pipeline. More information is available on the company’s website at www.tenaxthera.com and through its listings on the NASDAQ exchange.
